4883 Modalis Therapeutics
- 71
- +1+1.43%
Modalis Therapeutics News
Mincab, Inphonoid, Astroscale Holdings, etc.
<186A> Astroscale Holdings Inc. Okada Mitsunobu's shareholding ratio -% -> 21.98% Reporting obligation start date: June 5, 2024 <4436> Mincab the Infonoid Co., Ltd. Norway Bank (Norges Bank) shareholding ratio 5.55% -> 4.50% Reporting obligation start date: June 5, 2024 <4576> De Western Ceraptex Research Institute Co., Ltd. With Partner Co., Ltd.
Including Manabi Aid and Commerce One Holdings, etc.
<184A> Gakumibaido Co., Ltd. & KP Partners Co., Ltd. shareholding ratio - → 24.39%, report obligation date May 28, 2024<184A> Gakumibaido Co., Ltd. Hirose, Shuichi shareholding ratio - → 38.90%, report obligation date May 28, 2024<3070> Amagasa Co., Ltd. Mirai Intellectual Property Technology Research Institute Co., Ltd. shareholding ratio 17.51% → 0.00%, report obligation date 202
Medical net, Bank of Innovation, etc.
＜3645＞Medical Net Co., Ltd. SBI Securities Stock Ownership Ratio 6.18% → 4.43% Reporting Obligation Date 2024/05/15 ＜4074＞Raquel Co., Ltd. Tsutomu Kubo Stock Holding Ratio 47.79% → 44.50% Reporting Obligation Date 2024/05/16 ＜4393＞Bank of Innovation Co., Ltd. SBI Securities Stock Holding Ratio 6.17% → 5.81% Reporting Obligation
Modalis, GRCS, etc. [5% rule for emerging markets]
＜4175＞COLY Co., Ltd. Daichi Sasaki Stock Ownership Ratio 7.50% → 7.20% Reporting Obligation Date 2023/09/08＜4477＞BASE Co., Ltd. Tsuruoka Yuta Stock Holding Ratio 16.15% → 17.20% Reporting Obligation Occurrence Date 2024/05/09 ＜4564＞Oncotherapy Science Co., Ltd. Long Corridor Asset Management Limited (Long Corridor Asset M)
MODALIS THERAPEUTICS: Quarterly Report - 9th Quarter (2024/01/01 - 2024/03/31)
MODALIS THERAPEUTICS: Confirmation
MODALIS THERAPEUTICS: Financial results presentation for the 1st quarter of the fiscal year ending 2024/12
MODALIS THERAPEUTICS: Consolidated Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
Mitsubishi Heavy Industries, Toyota, ITOCHU, Yusen (8th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/8 (Wed) ＜1382＞Hove ＜1451＞KHC ＜165A＞SBI Leos ＜1768＞Soneck ＜1787＞Nakabotech ＜1814＞Daisue Ken＜1898＞Century Tokyu ＜1945＞Tokyo Enesis ＜2136＞
Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing Approach for the Treatment of LAMA2-deficient Congenital Muscular Dystrophy (LAMA2-CMD)
A breakthrough approach and supporting data using epigenome editing technology for the treatment of a type of muscular dystrophy, LAMA2-congenital muscular dystrophy (LAMA2-CMD), a genetic disorder, is presented. A
JFEHD, Yokogawa Electric, Nintendo, Kawasaki Ships (7 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/7 (Tue) ＜130A＞VIS ＜1333＞Maruha Nichiro ＜1723＞NEC ＜2003＞Nitto Fuji ＜2009＞Torigoe Powder ＜2053＞Chubukai ＜2281＞Prima Ham ＜2344＞Heian Rei ＜290
No plans (6 days) [Earnings Schedule]
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/6 (Mon) ---------------------------------------5/7 (Tue) ＜130A＞VIS ＜1333＞Maruha Nichiro ＜1723＞NEC ＜2003＞Nitto Fuji ＜2009＞Torigoe powder
Digital Plus, Genie, etc.
＜2370＞Medinet Co., Ltd. Macquarie Bank Limited Stock Ownership Ratio 5.55% → 4.49% Reporting Obligation Date 2024/04/22 ＜369＞Digital Plus McCauley Bank Limited Stock Ownership Ratio 15.79% → 14.54% Reporting Obligation Date 2024/04/09 ＜3905＞Data Section Hayashi Kento Co., Ltd. Stock Ownership Ratio 7.13% → 4.95%
Ewell, AB & Company, etc.
＜175A＞Wild Smart Co., Ltd. Ishii Yasuhiro Stock Ownership Ratio -% → 6.66% Reporting Obligation Date 2024/04/16 ＜175A＞Will Smart Co., Ltd. Zenrin Stock Ownership Ratio -% → 44.67% Reporting Obligation Occurrence Date 2024/04/16 ＜4563＞Angers Co., Ltd. Canter Fitzgerald Europe (Cantor Fitzgerald Europe) Stock Certificates
CHATWORK, DREAM ARTS, etc.
＜4431＞Smarregi Wishbone Management LP Co., Ltd. (WISHBONE MANAGEMENT LP) Stock Ownership Ratio 5.28% → 6.70% Reporting Obligation Date 2024/04/15 ＜4448＞CHATWORK CO., LTD. Asset Management One Co., Ltd. Stock Ownership Ratio 7.82% → 5.90% Reporting Obligation Date 2024/04/15 ＜4597＞Solasia Pharma Shares
AI, smart drives, etc.
＜1444＞Nisso acquires all shares of Heisei Housing, which handles the design, construction, sales, etc. of order/built-for-sale housing, etc., and made it a subsidiary ＜4388＞ AI upward revision, the first fiscal year operating profit forecast 0.81 billion yen ← 55 million yen ＜4444＞ acquisition of shares of brand design that handles infonet branding (employment/video, etc.), etc., and making it a subsidiary ＜4883＞ Modalis 1st Unsecured Convertible Bonds with Stock Acquisition Rights (with mass conversion price correction clauses) Number of shares issued from, 1
Modalis Therapeutics to See Reduced Expenses of 250 to 350 Million After Cutting Jobs
Modalis Therapeutics (TYO:4883) anticipates a reduction in expenses of 250 to 350 million yen following the laying off 15 personnel effective by the end of the month, resulting in lump-sum severance p
Qualips, blue innovation, etc.
＜157A＞Green Monster Co., Ltd. Nakamura Naoki Stock Ownership Ratio -% → 5.34% Reporting Obligation Date 2024/03/29 ＜157A＞Green Monster Co., Ltd. Toyota Arisa Stock Ownership Ratio -% → 8.73% Reporting Obligation Date 2024/03/29 ＜157A＞GREEN MONSTER CO., LTD. WM Partners Co., Ltd. Stock Ownership Ratio -% → 9.40% Reporting Obligation Date 2024/03
Technologies, Gladcube, etc.
＜4883＞Modalis SBI Investment Co., Ltd. Stock Ownership Ratio 5.54% → 4.91% Reporting Obligation Date 2024/04/03 ＜5248＞Technologies Co., Ltd. Long Corridor Asset Management Limited (Long Corridor Asset/Limited) Stock Ownership Ratio -% → 9.03% Reporting Obligation Occurrence Date 2024/04/08<95
Modalis Therapeutics to Reduce Stated Capital and Capital Reserves
Modalis Therapeutics (TYO:4883) intends to address its retained earnings deficit of 2.4 billion yen by reducing the amount of its stated capital and capital reserves and making an appropriation of oth
Analysis
Price Target
No Data
